Disability in childhood and the equity of health services: a cross-sectional comparison of mass drug administration strategies for soil-transmitted helminths in southern Malawi.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
05 Sep 2024
Historique:
medline: 7 9 2024
pubmed: 7 9 2024
entrez: 6 9 2024
Statut: epublish

Résumé

School-based approaches are an efficient mechanism for the delivery of basic health services, but may result in the exclusion of children with disabilities if they are less likely to participate in schooling. Community-based 'door to door' approaches may provide a more equitable strategy to ensure that children with disabilities are reached, but disability is rarely assessed rigorously in the evaluation of health interventions. To describe the prevalence and factors associated with disability among children aged 5-17 years and to assess the relative effectiveness of routine school-based deworming (SBD) compared with a novel intervention of community-based deworming (CBD) in treating children with disabilities for soil-transmitted helminths. DeWorm3 Malawi Site (DMS), Mangochi district, Malawi. All 44 574 children aged 5-17 years residing within the DMS. Disability was defined as a functional limitation in one or more domains of the Washington Group/UNICEF Child Functioning Module administered as part of a community-based census. Treatment of all children during SBD and CBD was independently observed and recorded. For both intervention types, we performed bivariate analyses (z-score) of the absolute proportion of children with and without disabilities treated (absolute differences (ADs) in receipt of treatment), and logistic regression to examine whether disability status was associated with the likelihood of treatment (relative differences in receipt of treatment). The overall prevalence of disability was 3.3% (n=1467), and the most common domains of disability were hearing, remembering and communication. Boys were consistently more likely to have a disability compared with girls at all age groups, and disability was strongly associated with lower school attendance and worse levels of education. There was no significant difference in the proportion of children with disabilities treated during SBD when assessed by direct observation (-1% AD, p=0.41) or likelihood of treatment (adjusted risk ratio (aRR)=1.07, 95% CI 0.89 to 1.28). Treatment of all children during CBD was substantially higher than SBD, but again showed no significant difference in the proportions treated (-0.5% AD, p=0.59) or likelihood of treatment (aRR=1.04, 95% CI 0.99 to 1.10). SBD does not appear to exclude children with disabilities, but the effect of consistently lower levels of educational participation of children with disabilities should be actively considered in the design and monitoring of school health interventions. NCT03014167.

Sections du résumé

BACKGROUND BACKGROUND
School-based approaches are an efficient mechanism for the delivery of basic health services, but may result in the exclusion of children with disabilities if they are less likely to participate in schooling. Community-based 'door to door' approaches may provide a more equitable strategy to ensure that children with disabilities are reached, but disability is rarely assessed rigorously in the evaluation of health interventions.
OBJECTIVES OBJECTIVE
To describe the prevalence and factors associated with disability among children aged 5-17 years and to assess the relative effectiveness of routine school-based deworming (SBD) compared with a novel intervention of community-based deworming (CBD) in treating children with disabilities for soil-transmitted helminths.
SETTING METHODS
DeWorm3 Malawi Site (DMS), Mangochi district, Malawi.
PARTICIPANTS METHODS
All 44 574 children aged 5-17 years residing within the DMS.
PRIMARY AND SECONDARY OUTCOME MEASURES METHODS
Disability was defined as a functional limitation in one or more domains of the Washington Group/UNICEF Child Functioning Module administered as part of a community-based census. Treatment of all children during SBD and CBD was independently observed and recorded. For both intervention types, we performed bivariate analyses (z-score) of the absolute proportion of children with and without disabilities treated (absolute differences (ADs) in receipt of treatment), and logistic regression to examine whether disability status was associated with the likelihood of treatment (relative differences in receipt of treatment).
RESULTS RESULTS
The overall prevalence of disability was 3.3% (n=1467), and the most common domains of disability were hearing, remembering and communication. Boys were consistently more likely to have a disability compared with girls at all age groups, and disability was strongly associated with lower school attendance and worse levels of education. There was no significant difference in the proportion of children with disabilities treated during SBD when assessed by direct observation (-1% AD, p=0.41) or likelihood of treatment (adjusted risk ratio (aRR)=1.07, 95% CI 0.89 to 1.28). Treatment of all children during CBD was substantially higher than SBD, but again showed no significant difference in the proportions treated (-0.5% AD, p=0.59) or likelihood of treatment (aRR=1.04, 95% CI 0.99 to 1.10).
CONCLUSION CONCLUSIONS
SBD does not appear to exclude children with disabilities, but the effect of consistently lower levels of educational participation of children with disabilities should be actively considered in the design and monitoring of school health interventions.
TRIAL REGISTRATION NUMBER BACKGROUND
NCT03014167.

Identifiants

pubmed: 39242171
pii: bmjopen-2023-083321
doi: 10.1136/bmjopen-2023-083321
doi:

Substances chimiques

Soil 0
Anthelmintics 0

Banques de données

ClinicalTrials.gov
['NCT03014167']

Types de publication

Journal Article Comparative Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

e083321

Informations de copyright

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Stefan Witek-McManus (S)

Department of Disease Control, London School of Hygiene and Tropical Medicine, London, UK stefan.witek-mcmanus@lshtm.ac.uk.

James Simwanza (J)

Blantyre Institute for Community Outreach, Blantyre, Malawi.

Rejoice Msiska (R)

Blantyre Institute for Community Outreach, Blantyre, Malawi.

Hastings Mangawah (H)

Blantyre Institute for Community Outreach, Blantyre, Malawi.

William Oswald (W)

Department of Disease Control, London School of Hygiene and Tropical Medicine, London, UK.

Joseph Timothy (J)

Department of Disease Control, London School of Hygiene and Tropical Medicine, London, UK.

Sean Galagan (S)

Department of Global Health, University of Washington, Seattle, Washington, USA.

Emily Pearman (E)

Department of Global Health, University of Washington, Seattle, Washington, USA.

Mariyam Shaikh (M)

Department of Global Health, University of Washington, Seattle, Washington, USA.

Hugo Legge (H)

Department of Disease Control, London School of Hygiene and Tropical Medicine, London, UK.

Judd Walson (J)

Department of Global Health, University of Washington, Seattle, Washington, USA.

Lazarus Juziwelo (L)

National Schistosomiasis and STH Control Programme, Community Health Sciences Unit, Ministry of Health & Population, Lilongwe, Malawi.

Calum Davey (C)

Department of Population Health, London School of Hygiene and Tropical Medicine, London, UK.

Rachel Pullan (R)

Department of Disease Control, London School of Hygiene and Tropical Medicine, London, UK.

Robin L Bailey (RL)

Department of Clinical Research, London School of Hygiene and Tropical Medicine, London, UK.

Khumbo Kalua (K)

Blantyre Institute for Community Outreach, Blantyre, Malawi.
Kamuzu University of Health Sciences, Blantyre, Malawi.

Hannah Kuper (H)

Department of Population Health, London School of Hygiene and Tropical Medicine, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH